Back to Results
First PageMeta Content
Chronic lower respiratory diseases / Smoking / Muscarinic antagonists / Thiophenes / Epoxides / Tiotropium bromide / Respimat / Chronic obstructive pulmonary disease / Acute exacerbation of chronic obstructive pulmonary disease / Medicine / Health / Pulmonology


SPIRIVA HandiHaler (tiotropium bromide inhalation powder) NDA # [removed]s029
Add to Reading List

Open Document

File Size: 809,92 KB

Share Result on Facebook

City

Ingelheim / /

Company

Medicine Marketed Products Respiratory Boehringer Ingelheim Pharmaceuticals Inc. / Astra-Zeneca / GlaxoSmithKline / Novartis / Dey Laboratories / Astra / Boehringer-Ingelheim / Experience / Osiris / Drug Regulatory Affairs Boehringer Ingelheim Pharmaceuticals Inc. / Pfizer 9 Background / M.D. / /

Facility

M.D. University of Texas Southwestern Medical Center Cardiology Samy Suissa / /

IndustryTerm

pharmaceutical / care of patients with pulmonary disease / /

MedicalCondition

bronchospasm / COPD / emphysema / chronic obstructive pulmonary disease / stroke / Presentation Overview COPD / pulmonary disease / COPD Donald P. Tashkin / chronic bronchitis / /

MedicalTreatment

pharmacotherapy / /

Organization

UCLA / National Institute of Health / University of Texas Southwestern Medical Center Cardiology Samy Suissa / FDA / McGill University / Florida Atlantic University / /

Person

Thor Voigt / Expertise Charles Hennekens / Donald Tashkin / Epidemiology Donald Tashkin / Steven Kesten / P.H. Florida / /

Position

Vice-President / Principal Investigator / Vice President / Professor of Medicine David Geffen School / Consultant / /

Product

SPIRIVA / /

SocialTag